ArticleSleep & breathing = Schlaf & Atmung2026
The prevalence of fibromyalgia syndrome in individuals with obstructive sleep apnea syndrome and the impact of continuous positive airway pressure treatment on fibromyalgia symptoms.
Article in Sleep & breathing = Schlaf & Atmung, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06595771 (The Incidence of Fibromyalgia in Patients with OUAS and the Effect of CPAP Treatment on Fibromiyalgia Symptom Severity), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Incidence of Fibromyalgia in Patients with OUAS and the Effect of CPAP Treatment on Fibromiyalgia Symptom Severity
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this study is to investigate the prevalence of Fibromyalgia Syndrome (FMS) in patients diagnosed with Obstructive Sleep Apnea Syndrome (OSAS) and to examine the effects of continuous positive airway pressure (CPAP) treatment on pain levels, symptom severity, functional level, depression, and the relationship between these parameters and polysomnographic data.
methodsA total of 251 patients aged between 30 and 65 years, diagnosed with OSAS and exhibiting symptoms for at least one year before diagnosis, were evaluated. 26 patients were excluded. Polysomnographic and demographic data were recorded. Patients were assessed for FMS by using the American College of Rheumatology criteria published in the years 1990 and 2016. Those diagnosed with FMS were evaluated by using the visual analog scale (VAS), Fibromyalgia Impact Questionnaire (FIQ), Fibromyalgia Fatigue Scale (FFS), Epworth Sleepiness Scale (ESS), and Beck Depression Inventory (BDI) before and 3 months after CPAP treatment. Pain threshold measurements were performed by using an algometer.
resultsFMS was detected in 43 of the 225 patients diagnosed with OSAS (19.1%). Fifteen of the 43 patients with FMS were excluded from the study due to irregular CPAP usage, and 28 patients completed the 3-months CPAP treatment and exercise program. Significant decreases in VAS, FIQ, FFS, BDI, and ESS values, and significant increases in pain threshold values were observed in these patients after CPAP treatment and exercise (p < 0.05).
conclusionCPAP treatment was associated with improvement FMS symptoms in patients with comorbidity of FMS and OSAS. This study revealed the importance of oxygenation and quality sleep in FMS. CLINICAL TRIAL REGISTRATION NUMBER : NCT06595771-Date of registration:04.09.2024 retrospectively registered.
Indexed as
Identifiers
41865211What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.